Presented at RDD 2021

Given patient convenience and compatibility with a range of formulations and doses, capsule-based dry-powder inhalation (cDPI) technology is an attractive DPI drug delivery platform for respiratory and systemic applications. Today, few options are available, and there is no one size fits all solution. This on-demand workshop covers the guiding principles around selection and customization of DPI capsules.


Meet the speakers

Julien Lamps 100 x 100.png

Julien Lamps

Product Manager 
Lonza Capsules and Health Ingredients

Julien Lamps graduated from Ecole Nationale Supérieure de Chimie de Lille with an Engineering degree in Chemistry in 2004. Julien joined Capsugel as a Quality Assurance Engineer in the Colmar plant in 2011. In this role, he worked at the interphase of Operations and Customers within the well-known Capsugel Quality Mindset. He specialized in coordinating new product introductions to develop innovative offers around modified release profiles and inhalation products. He is now Product Manager for Lonza’s Capsules and Health Ingredients business unit, focusing on the pharmaceutical capsules portfolio.

 fred_bordes_picard_100x100.png

Frédérique Bordes-Picard

Manager Pharmaceutical Business Development, Innovative Products
Lonza Capsules and Health Ingredients

Frédérique joined Capsugel (now Lonza) in 2010 as Pharmaceutical Business Development Manager, providing technical and regulatory support for new capsule-based product developments. Frédérique has developed specific expertise around capsule-based DPI product development & filing, supporting multiple companies in EMEA and US working on innovative or generic DPI projects.

Complete the form to watch the on-demand webinar.